Presence of DFS pattern should not be used to indiscriminately exclude presence of a rheumatic disease based on retrospective study in Abs 0814. RA, SS and Raynaud's ICD10 codes were higher among DFS pattern ANA per chart review. #ACR22 @RheumNow https://t.co/mLtppvR4dk https://t.co/6Lukxntqe7

• Clinical Correlation of Dense Fine Speckled (DFS) Pattern of ANA - ACR Meeting …

Biosimilar to biosimilar effective in treatment of RA/PsA/AxSpA. Large study looking at infliximab biosimilar switching - resulted in high retention rates and virtually no change in disease activity. @RheumNow #ACR22 Abs#1112 https://t.co/uNRXLewo4M

The greater the PsAID score, the more likely escalation in PsA treatment. Noted significant correlation between PsAID and physician global scores. Do you use PsAID in your clinic? Abs 1028 #ACR22 @RheumNow https://t.co/gcjm2XgPE3 https://t.co/bKPtXz5Nw8

• How Does PsAID Implementation Affect Treatment Intensification and Patient Sati…

Abstr #1494 determinants of clinically important worsening (CIW) of early axSpA - CIW = ASDAS ↑ > 0.9 b/w 2 visits - Tender Joint count and ASAS-NSAID score associated w/ CIW - MRI SI Jt inflammation & structural damage predictive of CIW @RheumNow #ACR22 https://t.co/Dgeh25BaWM

Global survey of rheumatic irAE people (me included) Standard case Variable answers, broadly distributed none are wrong We'll move from expert extrapolation of concepts to data-driven answers, with the right foundations👍 ABST0776 @MDAndersonNews @msalmazor #ACR22 @RheumNow https://t.co/5gMzWuCXd7

Do patients with PsA like online wellness programs? #ACR22 @RheumNow 🌈 186 patients, 86% women, 90% White 🌈sleep and nutrition were highly rated for wellness 🌈cost and fatigue barriers to adopting wellness behaviors 🌈 27% were open to an online wellness program

BASDAI and ASDAS performed similarly in axPsA pts, both demonstrating weak correlations w/ peripheral arthritis and moderate/strong correlations w/ pt fatigue and pain. Abs 1037 #ACR22 @RheumNow https://t.co/WRQx1hkIll https://t.co/kJVIWyVv2w

• Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients wit…

3 yr interim RELIANCE study analysis shows long-term CAN tx is safe and effective in CAPS regardless of the underlying mutation and TRAPS. Abs 0812 #ACR22 @RheumNow https://t.co/pgSq1IICJK and https://t.co/Y2NUpgXGPL https://t.co/j9DMFF7V8S

• 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-asso…
• Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic…

In clinic US guided entheseal biopsy? Abs 1025 at #ACR22 recommends the lateral epicondyle tendon plate in PsA pts. @RheumNow https://t.co/VomyFkecLq

• Entheseal Biopsy Approach: An Ultrasound-guided Method for Retrieval of Enthese…

Exposure to DMARDs prior to ICI treatment was not associated with 2-year crude mortality rates. Abs 0764 #ACR22 @RheumNow https://t.co/WvTy84Si7u https://t.co/X4RvYAVSMC

• No Impact of Prior DMARD Exposures on Mortality in US Veterans with Cancer Trea…

Window of opportunity in PsA CorEvitas registry: Early initiators had more severe disease & worse PROs but if DMARD therapy initiated within 1 yr: RR=2 MDA achievement & higher reduction of CDAI https://t.co/Xm9i7aiq85 Abs#1493 #ACR22 @Rheumnow https://t.co/RAGoHeuSIg

• Impact of Delay of Treatment with Disease Modifying Antirheumatic Drugs (DMARDs…

Performance BASDAI & ASDAS in evaluating PsA axial symptoms? 400+ pts DISCOVER 1&2 Weak correlations w/ peripheral arthritis Moderate/strong correlations w/ fatigue & pain Both perform similarly but do they perform well enough? https://t.co/alnrEXtydp Abs#1037 #ACR22 @Rheumnow https://t.co/Zuf1FruneK

• Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients wit…

Benefits with receiving anabolic agents upfront before antiresoprtives (as opposed to other way around). Shame about lack of access to this sequence currently @RheumNow #ACR22 #osteoporosis https://t.co/S2ttbrVaab

Low likelihood of syndesmophyte formation in PsA but is more likely assoc'd w/ axial involvement radiographically + high CRP. Abs 1014 #ACR22 @RheumNow https://t.co/M5Tc0fd64s https://t.co/e25gwVQKeo

• Is Radiographic Axial Involvement Associated with Syndesmophyte Development Aft…

DISCOVER 1 & 2: Subanalysis of GUS in 181 pts w/ Axial PsA and imaging confirmed SI GUS improves BASDAI, mBASDAI, spinal pain, morning stiffness, and ASDAS from W8 to W24 W24 Response rates BASDAI50 38% BASDAI70 20% https://t.co/MrS8atrIOI Abs#1035 #ACR22 @Rheumnow https://t.co/wMDkO1Qak9

• Efficacy of Guselkumab in Three Cohorts of Biologic-Naïve PsA Patients with Axi…